It might be the end of the work week for most, but it's the start of an exciting new chapter for our two newest #Synthegoats. Please help us in welcoming Ivy Li, our newest Senior Laboratory Associate joining the Clinical Operations team, and Hung Ly, our new Quality Control Manager, Analytical. We are excited to have you both on board!
Synthego Corporation
Biotechnology Research
Menlo Park, California 24,937 followers
The CRISPR Experts
About us
Synthego is a genome engineering company enabling the acceleration of life science research and development in the pursuit of improved human health. The company leverages machine learning, automation, and gene editing to build platforms for science at scale. By vertically integrating hardware, software, bioinformatics, chemistry, and molecular biology, Synthego is at the forefront of innovation advancing the next generation of medicines through providing access to genome editing at an unprecedented scale. //// Our Culture of Diversity: Different Faces from Different Places At Synthego, our differences make us unique, help us innovate, and allow us to persevere. We stand firmly behind our values, strive to achieve representation, and celebrate diversity in perspectives and backgrounds. We welcome all team members to be their best selves as we move forward towards fulfilling our shared vision of revolutionizing genome engineering technology to help make biological therapies accessible to all patients.
- Website
-
https://www.synthego.com
External link for Synthego Corporation
- Industry
- Biotechnology Research
- Company size
- 201-500 employees
- Headquarters
- Menlo Park, California
- Type
- Privately Held
- Founded
- 2012
Locations
-
Primary
3565 Haven Ave
Suite 1
Menlo Park, California 94025, US
Employees at Synthego Corporation
Updates
-
Ready to cut through the complexities of ordering CRISPR nucleases and gRNA? Our newly launched Ordering Help webpage makes it easier than ever to order our top-performing novel nucleases and best-in-class gRNA. Whether you are a gene editing pioneer, developing the next therapeutic, or need to restock your inventory of nucleases and gRNA, our easy-to-use ordering interface ensures you can place your order fast and efficiently without the hassle. Walk through how to order today! 👉 https://lnkd.in/gu2vJXVT #CRISPR
-
Cutting-edge CRISPR? We've maxed it out! Join Casey Jowdy, our Senior Product Manager, as he dives into the fidelity of our game-changing nuclease, hfCas12Max! 🧬 From outperforming traditional Cas nucleases to powering up your CRISPR-based therapeutics, hfCas12Max brings precision like never before. Plus, Casey will show how it fits perfectly within our RUO-to-GMP continuum. Check out the video to see how we’re pushing CRISPR to the max! 👉 https://lnkd.in/grXi9S_C #CRISPR
hfCas12Max: A Novel Nuclease for CRISPR-based Cell and Gene Therapies
synthego.com
-
Let's cut to the chase. CRISPR is unlocking new possibilities for developing therapies that save lives. Newly discovered and engineered CRISPR nucleases are providing an alternative path for therapeutic developers by expanding access to gene targets previously deemed uneditable using traditional gene editing techniques. These nuclease alternatives can also provide intriguing ways to protect your hard work and the possibility of marketing it, too. Learn more about the benefits of using alternative nucleases and how to license them in our latest blog. 👉 https://lnkd.in/gbcs-5y5 #CRISPR
-
🏌️♂️⛳️ Fore! It’s not all work in the lab—sometimes we swing for the greens too! 🏌️♀️ Our Synthego team swapped their pipettes for their golf clubs to hit the links. From perfecting our lab techniques to perfecting our putts, we had a tee-rific time soaking up the sun, sharing laughs, and creating lasting memories. At Synthego, we believe in balancing precision science with some fun on the fairway. After all, a little R&R can drive innovation! What’s your favorite way to unwind with colleagues? Share your thoughts below! 👇
-
Synthego Corporation reposted this
We’re thrilled to announce that our brand-new EditCo Bio Webstore is live now! https://hubs.la/Q02NS0Vj0 This change marks an exciting step forward in our commitment to providing you with a more tailored and seamless ordering experience designed explicitly for EditCo Bio customers. We’re excited about this next chapter and look forward to continuing to serve you with the best engineered cell products and services. Discover more: https://hubs.la/Q02NS0Vj0 #NewWebstore #ecommerce #EditCoBio #Biotech #GeneEditing #CellEngineering #CRISPR #Innovation #ResearchTools
-
🔎 Check out this new publication from St. Jude's on a promising therapeutic approach to Sickle Cell Disease. 🔥 Their latest research describes genome editing of hematopoietic stem cells to reactivate fetal hemoglobin (HbF). By targeting the γ-globin gene promoter, they achieved efficient editing and significant HbF induction, reducing sickling in patient-derived cells. Their rigorous preclinical approach, aligned with FDA guidance, emphasizes the importance of in vivo safety and efficacy studies and serves as a blueprint for future ex vivo cell therapies. 👉 https://lnkd.in/gFkpBJVr We are proud to support this work and look forward to following their progress through clinical trials! 👀
Development and IND-enabling studies of a novel Cas9 genome-edited autologous CD34+ cell therapy to induce fetal hemoglobin for sickle cell disease
cell.com
-
🔎 Exciting Opportunity! Register for tomorrow's insightful virtual town hall hosted by the FDA, "Cell Therapy CMC Readiness for Late-Stage INDs." As a leader in CRISPR-based CGT development, we’re eager to attend and explore the latest guidelines and best practices to ensure compliance, drive innovation, and better advise our clinical partners. This session is crucial for anyone involved in developing cutting-edge therapies. Don’t miss out on the chance to stay ahead of industry standards and enhance your strategies. Register now and be part of the conversation! https://lnkd.in/gvify5sK
OTP Town Hall: Cell Therapy CMC Readiness for Late-Stage INDs
fda.gov
-
After the long weekend, we thought we would ease you back into the LinkedIn feed with some positive news. We had 3 new #Synthegoats join us recently and we'd like to introduce them. Julie Pham is rejoining us as our new Director of Quality Assurance, Olin Blackmore has joined us as a Senior QC Stability Specialist, and Bjorn B. is the newest addition to our Clinical Production group as a Laboratory Associate II. Please join us in giving them a warm welcome!
-
Happy Labor Day! 🌟 Today, we celebrate the hard work, dedication, and achievements of all the amazing individuals who contribute to our success and growth. Whether you're relaxing with family or catching up on some well-deserved rest, take a moment to appreciate all that you’ve accomplished. Here’s to the collective effort that drives us forward and makes a difference every day. Enjoy the holiday! #LaborDay #HardWork #Teamwork #Celebrate